-
Access & communication tools
Economic Burden of Inflammatory Bowel Disease (IBD)
Topics covered within this infographic include how payors are likely aware that the incidence and cost of IBD are increasing but most of the spend for IBD is in the inpatient and emergency department.
-
Access & communication tools
Understanding Payor Drug Use Management Initiatives
In this downloadable infographic you’ll learn how several different tactics may be used as part of a drug use management strategy, the overall goal of which is to ensure appropriate medication use.
-
Access & communication tools
Managing Change in Health Care Insurance
Learn about challenges and solutions related to transitions in health care coverage, non-medical switching, site of care concerns, and emerging treatments.
Test your knowledge
This activity is intended to give you an opportunity to test your knowledge of the content contained in the infographics and other resources available on this portal. After submitting the quiz you will be given your score and additional information about the correct answer. Besides being a fun way to verify your understanding, the feedback is helpful to AGA to confirm the information was presented in an easy-to-understand manner.”
Testimonials
-
Dana McCormick, RPh, FAMCP, Optum
Senior Director, Pharmacy Advisory Services
“I have seen the influence of specialty society guidelines on payors’ decisions. Other than randomized clinical trials, specialty societies are the first place payors go to get more information.”
-
Rocio Castrillon, MBA, @VoiceForIBD
“I’ve often seen where a payor has the wrong contact information for the provider or perhaps the provider’s latest update says the approval is in ‘PA status’ and then somewhere in the timeline, it gets lost in the follow-up process. Patients are typically more aware of when prior authorizations aren’t going through due to immediate notifications and can oftentimes help do the follow-up work. Patients do tend to have more success with appeals when verbalizing the direct effects we are experiencing due to a delay in authorization. I believe having patients be able to do some of the follow-up allows for the opportunity for the patient to not only be proactive, but also not have to be sitting around waiting for an authorization to go through.”
